Paracetamol B. Braun (Paracetamol)

Paracetamol works by inhibiting cyclooxygenase enzymes, especially COX‑2, within the central nervous system. This inhibition reduces the production of prostaglandins, which are mediators of pain and fever, thereby providing analgesic and antipyretic effects without significant anti‑inflammatory activity.

The dose of Paracetamol B. Braun is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and liver function. Healthcare professionals follow established dosing guidelines and adjust the regimen as needed for safety and efficacy.

Safety data for intravenous paracetamol during pregnancy and lactation are limited. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and required import documentation.

Compared with other intravenous analgesics such as ibuprofen or opioid preparations, paracetamol offers effective pain and fever control with a lower risk of gastrointestinal irritation and respiratory depression. It is often used as part of multimodal analgesia to reduce opioid requirements.

Paracetamol B. Braun must be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. The vial should be kept in its original packaging until use to maintain sterility and stability.

The product is administered by a qualified healthcare professional as an intravenous injection. It may be given undiluted or diluted in compatible IV fluids, following aseptic technique and the prescribed infusion rate.

Serious risks include severe allergic reactions such as anaphylaxis, rare skin conditions like Stevens‑Johnson syndrome, and potential liver injury, especially with overdose or in patients with pre‑existing hepatic impairment. Prompt medical attention is required if any of these occur.

Paracetamol B. Braun should be avoided in individuals with known hypersensitivity to paracetamol or any excipients in the formulation, and in patients with severe liver disease. Caution is also advised for those with significant renal impairment or a history of severe allergic reactions to injectable medications.